Article
CDK5RAP3 as a Novel Biomarker Signature Predicting Survival and Adjuvant Chemotherapeutic benefit in Gastric Cancer
2020-12-21
Abstract excerpt
<title>Abstract</title> <p><bold>Background: </bold>We previously demonstrated that CDK5RAP3 acts as a tumour suppressor in gastric cancer through negative regulation of the Wnt/β-catenin signalling pathway, but its function in chemotherapeutic responsiveness of gastric cancer has not been investigated. In this study, we aimed to examine the clinical significance of CDK5RAP3 to predict chemotherapeutic responsive...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 834d0d0b-71d5-5dad-8cfb-8e88c76c8d98
- DOI
- 10.21203/rs.3.rs-130268/v1
